Also, I crave carbs much more strongly and cannot stand the taste of meat." 22
[8] [5] Inability to maintain adequate nutrition or medication adherence due to gastrointestinal symptoms is another important reason to contact a healthcare provider
Outstanding Questions GLP-1RA is a new type of drug for the treatment of T2MD
Conclusion Dietary modification personalized to individual preferences and treatment goals (e.g., caloric deficits of 500 kcal/day), combined with structured physical activity (e.g., 150 minutes of moderate-to-vigorous exercise per week), produces additive benefits beyond GLP-1 therapy alone, enhancing weight loss, improving body composition, and reducing visceral fat and inflammation
Their idea was backed up by the findings of Unger and other researchers like Keith Buchanan, a Scottish specialist in metabolic medicine at Queens University in Belfast, Northern Ireland (Marks 2018